Effectdossier · gearchiveerd kwartaal
IDYA
IDEAYA Biosciences, Inc. · Healthcare · Biotechnology
16Gevolgde houders
0Δ houders
43.75MGehouden aandelen
$919.60MGerapporteerde waarde
+1Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +5.5% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 100 | +4 | 68.09M | $2.53B | +10 | −5 |
| Q1 2026 | 98 | +2 | 72.39M | $2.41B | +9 | −8 |
| Q4 2025 | 96 | 0 | 74.31M | $2.57B | +1 | — |
| Q3 2025 | 17 | -1 | 45.06M | $1.23B | — | −2 |
| Q2 2025 | 16 | 0 | 43.75M | $919.60M | +1 | −1 |
| Q1 2025 | 13 | -1 | 14.55M | $238.33M | +1 | −2 |
| Q4 2024 | 14 | +1 | 14.99M | $385.22M | +1 | — |
| Q3 2024 | 12 | -1 | 10.73M | $339.97M | — | −1 |
| Q2 2024 | 13 | — | 11.98M | $420.72M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 13.14M | — | $276.15M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 13.14M | — | $276.15M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 13.14M | — | $276.15M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 8.84M | — | $185.87M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Point72 Asset Management ✦ | 5.03M | +3488.4% | $105.69M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passief) | 4.94M | — | $103.88M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passief) | 4.94M | — | $103.88M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (passief) | 4.94M | — | $103.88M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | The Vanguard Group ✦ (passief) | 4.94M | — | $103.88M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | The Vanguard Group ✦ (passief) | 4.94M | — | $103.88M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | State Street Global Advisors ✦ (passief) | 3.39M | -1.8% | $71.17M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passief) | 2.11M | +1.6% | $44.42M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Geode Capital Management ✦ (passief) | 2.11M | +1.6% | $44.42M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 1.90M | -45.2% | $40.04M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 30 | T. Rowe Price ✦ | 1.90M | -45.2% | $40.04M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 1.83M | +21.3% | $38.38M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 1.83M | +21.3% | $38.38M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Adage Capital Partners ✦ | 1.24M | +4.2% | $26.02M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Fisher Asset Management ✦ | 922.09K | -4.5% | $19.38M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Two Sigma Investments ✦ | 156.64K | -66.6% | $3.29M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | D. E. Shaw & Co. ✦ | 98.15K | -68.2% | $2.06M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Millennium Management ✦ | 66.69K | -87.8% | $1.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 35.84K | -1.8% | $753,252 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Wellington Management ✦ | 35.84K | -1.8% | $753,252 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | Wellington Management ✦ | 35.84K | -1.8% | $753,252 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | Wellington Management ✦ | 35.84K | -1.8% | $753,252 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 42 | Norges Bank ✦ (passief) | 30.59K | 0.0% | $642,981 | 0.0% | Held | 3 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 20.36K | Nieuw | $427,947 | 0.0% | New | 1 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 20.36K | Nieuw | $427,947 | 0.0% | New | 1 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 20.36K | Nieuw | $427,947 | 0.0% | New | 1 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 20.36K | Nieuw | $427,947 | 0.0% | New | 1 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 20.36K | Nieuw | $427,947 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| AQR Capital Management | $427,947 | 0.0% |
| AQR Capital Management | $427,947 | 0.0% |
| AQR Capital Management | $427,947 | 0.0% |
| AQR Capital Management | $427,947 | 0.0% |
| AQR Capital Management | $427,947 | 0.0% |
Verlaten
| Renaissance Technologies | $5.86M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 253 houders, 94.40M aandelen, $3.10B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API